Ozempic, a diabetes drug, shows promise for liver disease. Research indicates it can reverse non-alcoholic steatohepatitis. A ...

The FDA will decide whether to approve a once-daily, 25 mg oral formulation of semaglutide (Wegovy) by the end of 2025. If ...

At his home in Utah, Adrian wipes down all the surfaces in one room with isopropyl alcohol. He makes sure his HEPA filter is ...

The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.

Novo Nordisk’s oral Wegovy pill for chronic weight loss is under FDA review. If approved, it would be the first oral GLP-1 ...

Everything that happens in sports has additional context when viewed from a betting perspective. From season-changing injuries to record-setting moments and so much more, the news cycle will ...